SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Faeth Therapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Faeth Therapeutics, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 0.3%, MDD -19.0%).

Data 2021-02-04 ~ 2026-07-31daily bars 1,378 (5.5 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -38.1%, drawdown -98.7%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 23.8%, MDD -28.3%, Sharpe 0.47, 6% exposure.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 61.9%p higher than buy and hold, while drawdown improves by 70.4%p (CAGR 0.3%, MDD -19.0%, exposure 2%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=26, threshold=32
23.8%-28.3%0.470.843.2x46%
SMA 크로스오버
fast=43, slow=178
12.8%-69.2%0.450.191.9x522%
EMA 크로스오버
fast=57, slow=122
11.0%-70.6%0.430.161.8x320%
Donchian 채널 돌파
entryN=102, exitN=105
10.1%-74.6%0.420.141.7x319%
ROC 모멘텀
n=145, threshold=0.08
6.4%-75.1%0.390.091.4x3317%
Parabolic SAR
step=0.03, maxStep=0.12
-13.7%-91.5%0.20-0.150.4x12937%
Supertrend
period=29, mult=3.4
-18.9%-93.0%0.14-0.200.3x2345%
볼린저 밴드 돌파
n=17, k=3.5
0.3%-19.0%0.090.011.0x42%
MACD
fast=9, slow=15, signal=13
-36.5%-98.4%-0.05-0.370.1x12451%
Keltner 채널 돌파
emaPeriod=27, atrPeriod=6, mult=2.6
-8.2%-50.9%-0.13-0.160.6x96%
Buy and hold-38.1%-98.7%0.13-0.390.1x1100%
0.1 1x 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -28.3% (2026-02-24 → 2026-03-30), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next